All In MedTech

FDA Clearance Tracker · P140032-S047

Implantable System for Remodulin

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Oct 21, 2020 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Oct 21, 2020

Approved

Time to decision

303 days

Received Dec 23, 2019. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P140032-S047
Device name
Implantable System for Remodulin
Applicant location
Minneapolis, MN
Received
Dec 23, 2019
Decided
Oct 21, 2020
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P140032

Device type

Device class
Class III

Every decision under product code LKK

FDA's approval statement

As written in FDA's record.

Approval for design and manufacturing changes for the remediated pump changes and labeling corrections for the Implantable System for Remodulin.

Source documents

Other decisions for Medtronic, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.